Navigation Links
Mass. General study finds potential ovarian cancer stem cells

Massachusetts General Hospital (MGH) researchers have identified potential ovarian cancer stem cells, which may be behind the difficulty of treating these tumors with standard chemotherapy. Understanding more about the stem-like characteristics of these cells could lead to new approaches to treating ovarian cancer, which kills more than 16,000 U.S. women annually and is their fifth most common cause of cancer death. The report will appear in the July 25 Proceeding of the National Academy of Sciences (PNAS) and has received early online release.

"We feel these stem-like cancer cells may be resistant to traditional chemotherapy and could be responsible for the ultimately fatal drug-resistant recurrence that is characteristic of ovarian cancer," says Paul Szotek, MD, of the MGH Pediatric Surgical Research Laboratories, first author of the PNAS report. "We believe this likely is the first time stem-like cells have been found in models of ovarian cancer and in cells associated with human ovarian cancer."

Several recent studies have identified tiny populations of tumor cells that appear to act like stem cells, driving the tumor's ability to grow and spread. If some of these specialized cells escaped destruction by chemotherapy or radiation, the tumor would be able to recur quickly, often in a form resistant to chemotherapy. Similar cancer stem cells have been previously identified in leukemia and breast cancer and in cell lines of central nervous system and gastrointestinal tumors.

Standard treatment for ovarian cancer ?surgical removal of all involved tissues followed by chemotherapy ?usually appears successful, but treatment-resistant tumors recur in the vast majority of patients, leading to a five-year survival rate of less than 30 percent. Those factors and other observations suggested that cancer stem cells may also be found with ovarian tumors, leading to the current study.

The MGH researchers first examined two mouse ovar
'"/>

Source:Massachusetts General Hospital


Page: 1 2

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:
(Date:12/3/2009)... the past three years in the troposphere (lower atmosphere) ... results, which are the first of their kind in ... between 2002 and 2005. , Over recent years, physicists ... carbon dioxide (CO2) levels, and how these have evolved ...
(Date:12/2/2009)... an increased risk of developing lung cancer in adulthood, even ... are published in Cancer Epidemiology, Biomarkers & Prevention , ... part of a special tobacco focus in the December issue. ... be diagnosed with lung cancer; more than 159,000 will die ...
(Date:12/2/2009)... People who smoke their first cigarette within minutes after ... of nicotine when processed by the body, than those who ... , "Since cotinine levels appear to reflect ... who smoke immediately after waking may be especially at risk ...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Increased nicotine levels detected in those who light-up earlier 2Nexicon Technology to Protect Healthcare Industry 52924 1Nexicon Technology to Protect Healthcare Industry 52924 2Nexicon Technology to Protect Healthcare Industry 52924 3Nexicon Technology to Protect Healthcare Industry 52924 4Nexicon Technology to Protect Healthcare Industry 52924 5Must Haves for Your Summer Vacation Bag 52922 1Must Haves for Your Summer Vacation Bag 52922 2Must Haves for Your Summer Vacation Bag 52922 3Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 1Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 2Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 3Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 4Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications 13231 5
... have overcome a major hurdle to calculating how much ... vital information for understanding how the biosphere responds to ... can be safely emitted by human activities. The problem ... The key finding is that the compound carbonyl sulfide, ...
... shuttle Endeavour lifts off this month, its flight crew ... by the University of Alabama at Birmingham (UAB). ... freezers from the UAB Center for Biophysical Sciences and ... of the shuttle and the International Space Station (ISS). ...
... at The University of Texas at Austin, will present ... Greenhouse Gas Control Technologies that examines a unique storage ... CO2 escaping via buoyancy. , When: Nov. 19, about ... Calvert St. NW, in Washington, D.C. The research will ...
Other Biology News:Corralling the carbon cycle 2Compact research freezers to debut in space 2Engineer to present leak-proof method for carbon dioxide storage at international conference 2
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. ... on its European commercial launch of MuGard, an FDA ... of radiation treatment and chemotherapy. MuGard is commercially launched ... the UK, Germany, Italy, Norway, Greece and Sweden. Access ...
(Date:12/3/2009)... Caliper Life Sciences, Inc. (Nasdaq: CALP ), ... discovery and life sciences research, today introduced Living Image ... Image software drives the more than 800 Caliper IVIS ... features advanced spectral unmixing tools to enhance fluorescent sensitivity ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Carbondioxide Incubators - A Global Market ... ,, Incubators are the most critical equipment ... other applications for providing a controlled environment ...
(Date:12/2/2009)... 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the ... connection with its previously announced unit offering, the underwriters ... an additional 637,500 units. Each unit is comprised of ... purchase warrant, and was sold at a price of ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
... On the heels of a strong start to fiscal ... explain to investors this month where the company sees its ... and how it plans to achieve its goal of more ... 2012. Terry Crews, chief financial officer, and Carl Casale, executive ...
... Technologies (HeartIT®) today publicly announced the world,s first free website ... nothing but a standard web browser , ... ... Imaging Technologies (HeartIT®) today publicly announced the world,s first free ...
... AMSTERDAM, February 4 ,Agendia, a world leader ... signature breast cancer test MammaPrint(R) will be ... early stage breast cancer patients at the ... NKI-AVL,believes MammaPrint provides better guidance for decisions ...
Other Biology Technology:Monsanto Executives to Discuss Company's Growth Drivers, Profit Goals at Investor Conferences in February 2World's First Website for Patients to Share Diagnostic-Quality Medical Images 2Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL 2
Denhardt's Solution is a mixture of blocking agents used in membrane-based hybridization protocols. The solution contains 1% Ficoll (type 400) 1% polyvinylpyrrolidone and 1% bovine serum albumin. Ste...
... Feature Extraction Software reads and ... to prepare microarray data for ... one 1-year license for ... accounts , * one ...
... AquaMax DW4 liquid handling system from Molecular ... all in one instrument. The system handles ... and plate washing96-, 384- and 1536-welland is ... AquaMax DW4 has been optimized to dispense ...
... 10 O 2 S 2 ... White crystalline powder Assay: greater than ... IR Melting Point: greater than or ... than or equal to 1% ...
Biology Products: